Extendicare (OTCMKTS:EXETF – Get Free Report) and Bioqual (OTCMKTS:BIOQ – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.
Earnings and Valuation
This table compares Extendicare and Bioqual”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Extendicare | N/A | N/A | N/A | ($0.26) | -88.84 |
| Bioqual | $48.87 million | 0.59 | -$1.05 million | ($1.08) | -30.09 |
Insider & Institutional Ownership
9.4% of Extendicare shares are owned by institutional investors. 39.2% of Bioqual shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of current ratings and price targets for Extendicare and Bioqual, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Extendicare | 0 | 0 | 5 | 0 | 3.00 |
| Bioqual | 0 | 0 | 0 | 0 | 0.00 |
Profitability
This table compares Extendicare and Bioqual’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Extendicare | N/A | N/A | N/A |
| Bioqual | -2.27% | -2.69% | -1.50% |
Summary
Extendicare beats Bioqual on 7 of the 10 factors compared between the two stocks.
About Extendicare
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.
About Bioqual
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
